OncLive | Bringing the Global Oncology Community Together

Education ▼

Conference Coverage

Videos

NewsNetwork

OncLive^® TV

Peer Exchange

Insights

Attend An Event

State of the Science Summit

Regional Seminar Series

PER Conferences

Giants of Cancer Care

ISGIO

Webinars

OncLive Community

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Latest News

PROfound Data Could Lead to First PARP Inhibitor Approval in mCRPC

Alan H. Bryce, MD, discusses encouraging updates and emerging strategies in metastatic prostate cancer treatment. Read More >>

Guardrails Keep Oncology Waste Management on the Right Track

Emergence of Biosimilars Poised to Alleviate Financial Toxicity in Oncology

SOSS GU NASHVILLE 2019: Selecting Among AR-Directed Agents in Nonmetastatic CRPC

Fostamatinib Slated for EU Approval in Chronic ITP

EU Panel Backs Polatuzumab Vedotin Approval for DLBCL

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Genitourinary Cancers in Nashville

2019 State of the Science Summit on Hematologic Malignancies in Chicago

2019 New York Lung Cancers Symposium

2019 Chemotherapy Foundation Symposium

2019 Hairy Cell Leukemia Foundation Annual Conference

Dr. Borghaei on Emerging Biomarkers in NSCLC

Dr. Tauer on the Potential Implications of Biosimilars on Cancer Research Funding

Dr. Lonial on Treatments in Heavily Pretreated Multiple Myeloma

Dr. Perales on Ongoing Studies With CAR T Cells in DLBCL

Dr. Cohen on the Use of Chemoimmunotherapy in CLL

OncLive houses thousands of videos that provide updates and information.
See more Videos

PARP Inhibitors and Indications in Ovarian Cancer

Adverse-Effect Profiles of PARP Inhibitors in Ovarian Cancer

Molecular Testing for CCA

Role of Tumor Mutational Burden in NSCLC

CASPIAN Trial: Durvalumab and Chemotherapy in ES-SCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

New OS Data in Treatment for Nonmetastatic CRPC

Identifying Rare Mutations in NSCLC

MET as a Driver in NSCLC

Next Steps in Research for BRAF-Mutant NSCLC

TRK Inhibition: Future Challenges and Evolutions

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

ESMO Data Show More Can Be Done for Cancer of Unknown Primary Patients

Two research papers presented by Roche and Foundation Medicine at the 2019 European Society of Medical Oncology Annual Meeting demonstrate both the promise of an innovative precision medicine driven clinical trial (CUPISCO) for patients with cancer of unknown primary, as well as the challenges of identifying eligible patients for the trial.

View more >>>

Featured

TRK Inhibitors: Precision Medicine in Oncology

Benjamin Levy, MD; Mark Agulnik, MD; Marcia Brose, MD, PhD; Edward Kim, MD; John Marshall, MD; and Philip Agop Philip, MD, PhD, FRCP, discuss the use of TRK inhibitors in oncology.

View more >>>

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approval of a Biosimilar, Promising Data in Myeloma and GBM, and More